Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation

被引:53
作者
Anderson-Cohen, M
Holland, SM
Kuhns, DB
Fleisher, TA
Ding, L
Brenner, S
Malech, HL
Roesler, J
机构
[1] NIAID, Host Def Lab, Dept Lab Med, Bethesda, MD 20892 USA
[2] NCI, Bethesda, MD 20892 USA
[3] NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA
[4] Univ Clin Carl Gustav Carus, Dept Pediat, Dresden, Germany
关键词
NADPH-oxidase; CGD; chronic granulomatous disease; carrier; mutation; gp91-phox; X chromosome; inactivation; skewed; dihydrorhodamine;
D O I
10.1016/j.clim.2003.08.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic granulomatous disease (CGD) is an inherited immunodeficiency resulting from defects in the multienzyme complex NADPH-oxidase (phagozyte oxidase, phox), which normally produces microbicidal reactive oxygen metabolites (ROM). The reason for our patient's CGD was unusual, as revealed by the following in vitro findings in neutrophils and EBV-transformed B-cells: lack of flavocytochrome b(558) expression, restoration of significant ROM production after transduction with gp91-phox cDNA by a retrovirus vector, an 879G-->A, Trp289-->Stop mutation in one X chromosomal gp91-phox allele, a one-sided paternal X chromosome inactivation, as shown by a lyonization assay at the HUMARA locus, and the result of a dibydrorhodamine 123 flow cytometry assay revealing consistently that I in 2500 neutrophils produced ROM at normal levels. Our conclusion: A presumed autosomal form of CGD has been excluded. Instead, a spontaneous mutation in gp91-phox coinciding with an extreme X chromosome inactivation ratio resulted in X-linked CGD in this young woman. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:308 / 317
页数:10
相关论文
共 61 条
[21]   A FAST AND EASY METHOD TO DETERMINE THE PRODUCTION OF REACTIVE OXYGEN INTERMEDIATES BY HUMAN AND MURINE PHAGOCYTES USING DIHYDRORHODAMINE-123 [J].
EMMENDORFFER, A ;
HECHT, M ;
LOHMANNMATTHES, ML ;
ROESLER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 131 (02) :269-275
[22]   Regulation of X-chromosome inactivation in development in mice and humans [J].
Goto, T ;
Monk, M .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1998, 62 (02) :362-+
[23]   SEVERE ALPORT PHENOTYPE IN A WOMAN WITH 2 MISSENSE MUTATIONS IN THE SAME COL4A5 GENE AND PREPONDERANT INACTIVATION OF THE X-CHROMOSOME CARRYING THE NORMAL ALLELE [J].
GUO, CY ;
VANDAMME, B ;
VANRENTERGHEM, Y ;
DEVRIENDT, K ;
CASSIMAN, JJ ;
MARYNEN, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1832-1837
[24]  
Hendriks R W, 1993, Immunodeficiency, V4, P263
[25]   Hematologically important mutations: X-linked chronic granulomatous disease (Second update) [J].
Heyworth, PG ;
Curnutte, JT ;
Rae, J ;
Noack, D ;
Roos, D ;
van Koppen, E ;
Cross, AR .
BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (01) :16-26
[26]   CHRONIC GRANULOMATOUS-DISEASE - DIAGNOSIS AND CLASSIFICATION AT THE MOLECULAR-LEVEL [J].
HOPKINS, PJ ;
BEMILLER, LS ;
CURNUTTE, JT .
CLINICS IN LABORATORY MEDICINE, 1992, 12 (02) :277-304
[27]   CYBB mutation analysis in X-linked chronic granulomatous disease [J].
Jirapongsananuruk, O ;
Niemela, JE ;
Malech, HL ;
Fleisher, TA .
CLINICAL IMMUNOLOGY, 2002, 104 (01) :73-76
[28]  
Kubota T, 1999, AM J MED GENET, V87, P258, DOI 10.1002/(SICI)1096-8628(19991126)87:3<258::AID-AJMG12>3.0.CO
[29]  
2-Q
[30]   LUPUS ERYTHEMATOSUS-LIKE ORAL MUCOSAL AND SKIN-LESIONS IN A CARRIER OF CHRONIC GRANULOMATOUS-DISEASE - CHRONIC GRANULOMATOUS-DISEASE CARRIER GENODERMATOSIS [J].
LOVAS, JGL ;
ISSEKUTZ, A ;
WALSH, N ;
MILLER, RAW .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1995, 80 (01) :78-82